It seems like being somewhat skeptical would be an inherent part of being a biomedical scientist. But not always it seems. On the other hand, some of us take it to another level by science blogging out our skepticism about certain topics. Note that there’s something called the Skeptics Society that publishes a magazine Skeptic. […]
As Neuroskeptic blog ends, reflections on skeptical science blogging Read More »
After all this time writing on The Niche here since 2010, I still haven’t entirely resolved certain blogging dilemmas including when a patient discloses something. It’s kind of a jungle out there on the internet. What kinds of tough blogging dilemmas do I face? I’m just going to give you some examples of the more common
Stem cell blogging dilemmas: patient disclosures, lawsuits, & more Read More »
What is the future of Genome Medicine? The meeting by that same name that I’m at down here in La Jolla is all about tackling this question and the line up of speakers today on the first day is amazing. I’m speaking about IPS cells as a basis for personalized medicine tomorrow morning so that’s exciting.
Live blogging Future of Genome Medicine: great talks by Feng Zhang & others Read More »
The FDA is holding its first 2016 stem cell meeting today and you can read about some impressions of the morning session of this meeting here. In this post, I’m focusing on the afternoon session, which has been mostly on policy and ethics, including on stem cell clinics. Jonathan Kimmelman from McGill University got the afternoon going
Blogging today’s FDA stem cell meeting: Part 2 Clinics, Policy & Ethics Read More »
The FDA is holding its first 2016 stem cell meeting today. How’s the meeting going? The meeting start awfully early for us West Coast folks (5:30am) so I didn’t get to see the first few talks. Did anyone else see those and if so, what was your impression? From the talks I have seen, this meeting
Blogging today’s FDA stem cell meeting: Part 1 Read More »
Starting tomorrow I’m going to be at the ISSCR 2016 meeting live blogging it in San Francisco. The annual ISSCR meeting is a great place to hear about all the latest research from basic findings to reports on pre-clinical and clinical studies. There are always valuable and unique insights from chatting with people too. I
Live Blogging ISSCR 2016 SFO Read More »
There’s a great meeting going on today here at UC Davis starting soon on CRISPR, focused on the intersection of the science with bioethical and legal issues. I’ve been helping to organize this meeting, but kudos and thanks go to my colleague Mark Yarborough who took the lead in organizing the meeting and did most
Blogging UC Davis CRISPR Science & Bioethics Meeting Read More »
Now we have an interesting panel starting on questions of governance on human gene editing. This will focus on institutional and national levels of governance. Pilar N. Ossorio, University of Wisconsin, Madison, and Morgridge Institute for Research, is introducing the panel. Key question: how should emerging technologies being governed? Jonathan Kimmelman, from McGill, was the first
Live Blogging #GeneEditSummit Day 2 Post #1: Governance of human gene editing Read More »
This is post #4 of my live blogging of the #GeneEditSummit today. It is focused on societal implications so I’m really looking forward to it. You can read posts 1-3, here, here, and here summarizing the talks and key points from the meeting so far. Annelien L. Bredenoord, University Medical Center Utrecht, chaired the session. John Harris,
Live Blogging #GeneEditSummit Day 1 Post #4: Societal Implications of human gene editing Read More »
The post-lunch session is “Applications of Gene Editing Technology: Human Germline Modification”. Prior to hearing it I’m curious how cautious or gung-ho the speakers will be, or if their gestalt will be one of balance in the middle somewhere. Robin Lovell-Badge, The Francis Crick Institute, was the moderator of this session. He said, “We’d be
Live Blogging #GeneEditSummit Day 1 Post #3: human germline modification Read More »